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Abstract 
Background: To find out the association of 
intrauterine growth retardation (IUGR) with 
maternal hypertension. 
Methods: In this case control study 124 cases and 
249 controls (thus giving the case to control ratio of 
1:2.) were enrolled. All were  born full term and 
delivered in obstetrics department . After taking 
verbal consent for the study the mothers were 
interviewed for the presence or absence of 
hypertension during pregnancy and their antenatal 
records checked (if available). To rule out the 
confounders, a study proforma was used to record 
maternal hypertension, maternal height, weight, 
BMI, age, anemia, socioeconomic status, 
preeclampsia, eclampsia, number of children, age of 
last born, gender, mode and date of delivery. Cases 
and controls were identified and assigned an 
identification number. All the study cases were seen 
by the pediatrician on the first day of life, weighed 
properly, their length and head circumference noted 
and plotted on centile charts in accordance with their 
gender to note the presence or absence of intra 
uterine growth restriction (IUGR). A p-value of 0.05 
or less was used to see the significance of the 
association.  
Results: Mothers of small for gestational age (SGA) 
babies were more than two times likely to have 
hypertension. Both low maternal BMI and Anemia 
in mother were significantly associated with IUGR 
in both univariate and multivariate analysis. 
Socioeconomic condition was also showing 
significant association with IUGR.  Other factors like 
gravidity, maternal age, parity were not showing any 
association with IUGR. 
Conclusion: Maternal anemia and low BMI are 
showing strong association with IUGR while 
maternal hypertension is not showing a strong 
association.   
Key words: Maternal hypertension, Intrauterine 
growth retardation, Small for gestational age  
Introduction 
The term intrauterine growth retardation (IUGR) or 
Small for gestational age (SGA) is generally used for 
fetuses weighing less than the tenth percentile for 
gestational age or less than two standard deviations 
below the mean for gestational age.1 The factors 
responsible for IUGR are fetal, placental, 
environmental and maternal. IUGR affects 23.8% of 
new borns around the world and 75% of these affected 
infants are born in Asia. In Pakistan incidence of IUGR 
is around 25%.2,3 
Among the maternal factors, hypertension is one of the 
main factors related with IUGR.4 Both chronic 
hypertension and PIH are associated with low birth 
weight.5 Even if the pregnant women with chronic 
hypertension do not develop pre eclampsia, 
hypertension in the presence of proteinuria will lead to 
restricted fetal growth.6 The term maternal 
hypertension is used when a blood pressure of 
140/90mmHg or increase in systolic pressure of at 
least 30mmHg or an increase of at least 15mmHg 
diastolic pressure over the baseline first trimester 
readings is observed. 
The hypertension in pregnancy may be seen, as 
preeclampsia (hypertension with proteinuria), 
eclampsia (preeclampsia with seizure activity) and 
pregnancy induced hypertension (hypertension 
without proteinuria).Hypertension has its role in fetal 
growth restriction throughout the pregnancy. Usually 
from conception till 24 weeks of gestation, it is the 
chronic hypertension responsible for IUGR. From 24 
weeks onwards, it is the pregnancy induced 
hypertension ( PIH) that leads to IUGR.7 PIH is one 
factor that is related to parity also. Chronic 
hypertension is associated with increased fetal risk.8 
Studying the pathophysiology of IUGR reveals that 
maternal disorders like preeclampsia, eclampsia, 
chronic reno vascular disease and chronic 
hypertension lead to IUGR by causing uteroplacental 
insufficiency. Due to decreased oxygenation of tissues, 
the organ growth and muscular maturation is 
impaired. Preeclampsia can cause placental infarction 
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that disturbs the provision of nutrients and leads to 
IUGR and  poor placental flow and hence poor 
oxygenation of tissues cause restricted fetal growth.9 
Preeclampsia occurring in the later part of pregnancy 
can lead to asymmetric form of IUGR because more of 
the blood is directed towards the vital organs like 
brain and the head is comparatively spared. As a 
result of chronic hypoxia due to placental insufficiency 
polycythemia occurs in the fetus. When scanning is 
being done to detect IUGR hypertension in the mother 
is one of the corroborative signs needed to support the 
diagnosis.10 
The control of hypertension by various drugs like 
methyldopa, labetalol, calcium channel blockers like 
nifedipine and ACE inhibitors has a role in the 
outcome of pregnancy. Regular antenatal checkups are 
an important part of management regarding the 
detection of hypertension. The treatment of extreme 
preeclamptic hypertension includes the use of drugs 
like hydralazine, labetalol, nitroglycerine or sodium 
nitroprusside. Magnesium sulphate is also used for the 
treatment or prevention of preeclampsia.11 
Complications of IUGR and SGA are many and 
include higher risk of perinatal mortality and sudden 
infant death syndrome. At any gestational age, the 
morbidity and mortality are increased among term 
infants whose birth weights are at or below 3rd 
percentile for gestational age. SGA babies are prone to 
perinatal asphyxia and hypoglycemia in the first 
twenty four hours after birth.12 
Patients and Methods 
Study was conducted in Paediatric department 
(Neonatal intensive care unit) and in Obstetrics and 
Gynecology department of Holy Family Hospital 
Rawalpindi from  June 2006 to Feb 07. The sampling 
technique was Convenience sampling.  Total 124 cases 
and 249 controls (thus giving the case to control ratio 
of 1:2.) were enrolled in this study, that are born full 
term and delivered in obstetrics department of Holy 
Family Hospital, Rawalpindi. Admitted newborns 
were seen in the Neonatal Intensive Care Unit while 
those being kept with the mother after delivery were 
seen in the Obstetrics and Gynecology Department. 
After taking verbal consent for the study the mothers 
were interviewed for the presence or absence of 
hypertension during pregnancy and their antenatal 
records checked (if available). To rule out the 
confounders, a study proforma was used to record 
maternal hypertension (as defined earlier) maternal 
height, weight, BMI, age, anemia, socioeconomic 
status, preeclamsia, eclampsia, number of children, 
age of last born, gender, mode and date of 
delivery.Cases and controls were identified and 
assigned an identification number. All the study cases 
were seen by the pediatrician on the first day of life, 
weighed properly, their length and head 
circumference noted and plotted on centile charts in 
accordance with their gender to note the presence or 
absence of IUGR.  
Results 
Majority were in age group 20 to 30 years (Table 1). 
Primigravida were 49 (39.2%)  in case group and 100 
(40%) in control group (Table 2). Out of the cases, 52 
(42.6%) were delivered by SVD and 70 (57.4%) were 
delivered by LSCS. The number of controls delivered 
by SVD were 95 (38.2%) and 154 (61.8%) of the 
controls were delivered by LSCS. Out of the cases, 69 
(55.2%) were males and 56 (44.8%) were females. Out 
of the controls, 157 (62.8%) were males and 93 (37.2%) 
were females. The  Univariate analysis  obtained 
showed association of IUGR with different maternal 
factors. Majority (61.6 %) of the cases and 211(84.4%) 
of the controls did not have maternal hypertension 
(OR 1).48 (38.4%) of the cases and 39 (15.6%) of the 
controls were having maternal hypertension (OR 2.2; 
p-value .004). Only 2 (1.6%) of the cases and 6 (2.4%) 
of the controls were having teenage mothers (OR 1.01) 
while 123 (98.4%) of the cases and 244 (97.6%) of the 
controls did not have teen age mothers (OR 1;p-value 
.989). Seventy three  (58.4%) of the cases and 204 
(81.6%) of the controls were having mothers with 
normal weight (OR 1). 52 (41.6%) of the cases and 
46(18%) of the controls were having thin mothers (OR 
2.9;p-value <.001). Thirty seven  (29.6%) of the cases 
and 203 (81.2%) of controls were not having anemia in 
mothers (OR 1) while 88 (70.4%) of cases and 47 
(18.8%) of the controls were having anemia in mothers 
(OR3.2;p-value <.001). 66 (52.8%) of the cases and 219 
(87.6%) of the controls had mothers with normal (25+) 
BMI (OR 1) while 59 (47.2%) of the cases and 31 
(12.4%) of the controls had thin mothers with a BMI of 
< 25(OR 3.7;p-value <.001) (Table 3). 
In the univariate analysis, the weight of the newborn 
in our dataset ranged from 1.2kg to 3.8kg.A binary 
dependent variable termed as intrauterine growth 
retardation(IUGR) was created where newborns 
having birth weight <2.2kg were IUGR. Univariate 
logistic regression analysis was done with biological 
characteristics of the mother which were considered as 
possible risk factors for IUGR. Independent variables 
were converted into dichomotous variables for ease of 
analysis and clarity. In the univariate analysis cases 
compared to controls were more than two times likely 
to have their mothers having hypertension(OR 
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2.2,95%CI 1.3-3.6), and almost three times likely that 
their mothers would be underweight (OR 2.9,95% CI 
1.7-4.8),over three times likely to have their mothers 
anemic (OR 3.2,95% CI 2.3-4.3)Table 6. Cases 
compared to controls showed that the mothers of the 
cases were four times likely to have a low BMI (OR 3.7, 
95%CI 2.2- 6.2).  
Table 1: Maternal age 
Maternal age Case Control  
17to 19years 
 
2 (1.6%) 6 (2.4%) 
20 to 30 years 
 
107(85.6%) 219(87.2%) 
 
31 to 35 years 
 
13 (10.4%) 23 (9.2%) 
36 years and above 
 
3 (2.4%) 3 (1.2%) 
Table 2: Number of  children born 
Characteristic Cases  Controls p-value 
(chi-sq) 
Primigravida 49 100 0.777 
2-4 children 54 113 
5-12 children 22 37 
Total 125 250   
Table 3: Univariate analyses showing association of 
IUGR  with maternal factors 
Variable Cases 
(Number) 
  
Controls 
(Number) 
Odds 
ratio 
(OR) 
p-
value 
(95% 
CI) 
Hypertension  
No 77 221 1 0.004 
(1.3-3.6) Yes  48 39 2.2 
Mothers’ weight 
Normal 
 (1-80 kg) 
73 204 1 <0.001 
(1.7-
4.8) Thin (upto 
60 kg) 
52 46 3.2 
Anaemia  
No 37 203 1 <0.001 
(2.3-
4.3) 
Yes 88 47 3.2 
Mothers’ BMI 
Normal 
(25+) 
66 219 1 <0.001 
(2.2-
6.2) Thin 
(<25) 
59 31 3.7 
Hypertension however has shown a weak and non 
significant association and therefore has been 
discarded. A multivariate regression analysis model 
was developed by including those variables whose 
significance level was 0.02 or below. Many interactions 
were tried and variables were added to the model to 
look for confounding factors. Hypertension was not a 
significant factor and therefore was removed from the 
model. The risk factors associated with IUGR in the 
final model shows that cases compared to controls 
were greater than five times likely to have their 
mothers having anemia ( Adjusted OR 5.17, p-value 
<.001, 95%CI 2.98-8.96), and their mothers would more 
than twice likely to be thin having BMI <20 (Adjusted 
OR 2.67, p-value .001, 95%CI 1.49-4.77) (Table 4).  
Table 4: Multivariate logistic regression model 
showing association of independent variables to 
IUGR 
Independent 
variable 
Adjusted OR p-value 95% CI 
Maternal anaemia  
No 1 0.001 2.98-8.96 
Yes 5.17 
Mothers’ BMI 
Normal 1 0.001 1.49-4.77 
Thin 2.67 
 
Discussion 
The present study (a case- control study) shows that 
intrauterine growth retardation is poorly related to 
maternal hypertension. The other factors having a 
significant relation to intrauterine growth retardation 
were maternal anemia, maternal body mass index, 
maternal age and family income.12-14Intrauterine 
growth retardation was seen more in newborns with 
gestational age in the range of 37 to 38 weeks gestation 
as compared to those delivered at 39 to 41 weeks of 
gestation.  
The results of the study differ from various studies 
conducted in various parts of the world which showed 
that maternal hypertension during pregnancy was 
associated with intrauterine growth retardation. 4,5,10  
In present study maternal hypertension was poorly 
associated with intrauterine growth retardation. In the 
univariate analysis of our study, it was found that 
cases compared to controls were more than two times 
likely to have their mothers having hypertension. The 
calculated p-value for this maternal factor was .004. In 
our study maternal hypertension was found in 38.4% 
of the cases and 15.6% of the controls. The results of 
our study are also different from the study conducted 
in our country by Muhammad T et-al which showed  
preeclampsia and eclampsia as possible causes for low 
birth weight of the fetus.15 The study by Mohammad T 
also stated that low birth weight of the newborn was 
associated with both primiparity and grand multi 
parity. In our study, out of the cases 39.2% had 
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primigravida mothers, those with 2 to 4 children were 
43.2% and 17.6% of the cases had mothers with 5 to 12 
children while among the controls, 40% were born to 
primigravida mothers, 45.2% were having mothers 
with 2 to 4 children and 14.8% were those whose 
mothers had 5 to 12 children. The p-value calculated 
for this characteristic was 0.777. As shown by the 
figures mentioned, our results did not show any 
significant difference in the two groups (cases and 
controls) regarding this demographic characteristic i.e. 
parity of the mother .       
 Our study has shown results different from those 
shown in a study by Ayaz et al in Abbottabad, their 
study showed that young age of the mother, maternal 
hypertension, and close birth spacing was the risk 
factors for low birth weight of the newborn.16  Our 
results are different from this study because no 
significant association of growth retardation of the 
newborns was found with young age of the mother. 
Regarding the maternal age, in our study the 
univariate logistic regression analysis revealed that out 
of all the cases only 1.6% had mothers in the teenage 
group (17 to 19 years). The results of our study are also 
different from a study conducted abroad which 
showed that maternal age at delivery was significantly 
associated with poor pregnancy outcomes like low 
birth weight.17 In our study no such association of 
maternal age with low birth weight of the newborns 
was seen. 
The results of our study correspond to the study 
carried out by  Khan MN  et al which showed that 
maternal body mass index (BMI) was related to the 
birth weight of the newborn.  18 In this study it was 
recommended that pre pregnancy weight gain should 
be attained to reduce the incidence of low birth weight 
in newborns. In our study 47.2% of the cases were 
having mothers with BMI less than 25 while out of all 
the controls 12.4% were having mothers with a BMI of 
less than 25.52.8% of the cases were having a maternal 
BMI of 25 and above and 87.6% of the controls were 
having maternal BMI in the same range . 
 Body mass index is calculated by dividing the weight 
in kilograms by surface area of the body in meter 
squares. If we ignore the racial factors and consider 
malnutrition as the main factor in the causation of 
decreased weight then our results also correspond to 
the study done by Rehman  et al  where maternal 
malnutrition, anemia was considered a factor of 
unique importance for intrauterine growth 
retardation.19 
The univariate logistic regression analysis revealed 
that the mothers of the cases were almost four times 
likely to have a low BMI (OR 3.7, 95% CI 2.2-6.2) The 
final multivariate model for detecting association of 
independent variables to intrauterine growth 
retardation showed that the mothers of cases would be 
more than twice likely to be thin having BMI less than 
20 (Adjusted OR 2.67, p-value .001, 95% CI 1.49-4.77). 
Intrauterine growth retardation was a perinatal 
outcome related to maternal anemia. 20  Our study also 
corresponds to a study done in Zimbabwe  where it 
was shown that iron supplementation during 
pregnancy was associated with higher birth weights of 
newborns independent of other pregnancy care 
factors, nutritional status of the mother, smoke 
exposure and a number of demographic and 
socioeconomic factors.21,22 Our study has shown strong 
correlation of intrauterine growth retardation with 
maternal anemia. 88% of the cases had mothers with 
anemia while 18.8% of the controls were having 
mothers with anemia. The univariate logistic 
regression analysis revealed that the cases are over 
three times likely that their mothers would be anemic ( 
OR 3.2,95% CI 2.3-4.3). The results of our study are 
also corresponding with those of a study conducted By 
Moin A et al and Imdad A et al  showing a significant 
correlation of birth weight of the newborn, maternal 
body weight and hemoglobin level.  23,24 The final 
multivariate analysis of our results revealed that cases 
compared to controls were greater than five times 
likely to have their mothers having anemia .  
The results of our study resemble the study carried out 
by Fikree FF et al , which was a prospective study for 
determinants of low birth weight of the babies. 25 Their 
study showed that 46% of the low birth weight babies 
belonged to the low socioeconomic group. In our 
study when the various demographic characteristics of 
the cases and controls were compared it was found 
that the difference between cases and controls was 
significant (p- value<.001). 88% of the cases were 
having a family income in the range of 3001 to 10000 
while 51.6% of the controls were having family income 
in this range. 28% of the cases were having a family 
income in the range of 10001 to 20000 and 46.4% of the 
controls were having family income in the same 
range.According to the results of the study, maternal 
anemia, low body mass index of mother and low 
socioeconomic conditions play a major role in 
causation of growth retardation of the neonates. 
Maternal factors like cigarette smoking, alcohol intake 
and drug abuse ,playing a definite role in the 
incidence of low birth weight of the newborn in the 
west, are not significant in our set up. 
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Conclusions  
1. The maternal factors having a significant role in 
causation of intrauterine growth retardation are 
low body mass index of mother, anemia in the 
mother and poor socioeconomic conditions. 
2. Intrauterine growth retardation is not related to 
parity or young age of the mother. 
3. Hypertension is not strongly associated with 
intrauterine growth retardation. 
4. Efforts should be made to ensure proper weight 
gain by the mother during pregnancy. This can be 
done by education of the mother through sessions 
related to nutrition during pregnancy, proper 
follow up and regular antenatal checkups. 
5. Anaemia in the mother should be detected early 
through regular antenatal check ups and iron 
supplementation should be done in pregnant 
mothers. Nutritional programmes should be 
arranged in all centers to provide proper food and 
other micro nutrients to the mothers. Correction of 
anemia in the teenage before marriage can 
improve the situation. 
6. Early antenatal diagnosis of intrauterine growth 
retardation through ultrasonic examination is 
necessary to reduce the fetal morbidity and 
mortality. 
7. High quality obstetric and pediatric units should 
be established by the government to provide low 
cost and accessible services to the low income 
groups.  
8.  
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